Efficacy and safety of dupilumab as add-on therapy for patients with severe asthma: A real-world Dutch cohort study
John C. Thelen, Cathelijne M. van Zelst, Sigrid E. van Brummelen, Simone P. Rauh, J.C.C.M. in ’t Veen, Jasper H. Kappen, Gert‐Jan Braunstahl
Topics & Concepts
MedicineDupilumabExacerbationInternal medicineCohortAsthmaAdverse effectClinical endpointQuality of life (healthcare)Clinical trialNursingAsthma and respiratory diseasesAllergic Rhinitis and SensitizationDermatology and Skin Diseases